Target intelligence / Profile preview

Glycine-N-acyltransferase like 1 (GLYATL1)

Target
GLYATL1
Molecular classification
Enzyme, Acyltransferase
01

Overview

Glycine-N-acyltransferase like 1 (GLYATL1) is a mitochondrial enzyme belonging to the acyltransferase family, closely related to glycine N-acyltransferase (GLYAT). It catalyzes the transfer of acyl groups from acyl-CoA donors (such as phenylacetyl-CoA) to amino acids like glutamine or glycine, forming conjugated amino acid derivatives that are important in the metabolism and detoxification of endogenous and xenobiotic compounds. The protein is mostly found in human tissues such as the liver and is involved in phase II metabolism, which facilitates the excretion of potentially harmful compounds. While GLYATL1 participates in essential metabolic processes and acts as an enzyme, there is little evidence to date that it is directly implicated as a driver in major disease pathways; it is, however, associated with glutamine metabolic processes and may be related to select metabolic disorders[2][3][4].

Other names
Acyl-CoA:glycine N-acyltransferase-like protein 1Glutamine N-acyltransferaseGNAT2.3.1.68
02

Mechanism of action

Enzyme catalyzes transfer of an acyl group from acyl-CoA (such as phenylacetyl-CoA) to an amino acid (such as glutamine or glycine)[2][4]. Essential for conjugation of certain carboxylic acids, aiding in detoxification and excretion.

03

Biological functions

Glutamine N-acyltransferase activityGlycine N-acyltransferase activityAmino acid conjugationBiotransformation (Phase II metabolism)Glutamine metabolism
04

Disease associations

Other (very limited evidence connects GLYATL1 directly with specific diseases, but associated with metabolic pathways and potentially implicated in conditions such as Dependent Personality Disorder and Complement Component 7 Deficiency[4])
05

Interacting drugs

long-chain acyl-CoA derivatives (e.g., oleoyl-CoA, in vitro inhibitors)

Beyond the preview

Go deeper on Glycine-N-acyltransferase like 1 (GLYATL1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycine-N-acyltransferase like 1 (GLYATL1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call